Menu

U.S. Rep. Jason Smith (R-Mo.) at a Ways & Means Committee hearing

U.S. Rep. Jason Smith (R-Mo.) began the House Ways & Means Committee’s hearing by arguing that large hospital systems “manipulate the 340B drug pricing program to keep steep drug discounts for themselves instead of passing the savings to low-income patients.”

News Alert

UPDATED: GOP Lawmakers Accuse Urban Hospitals of Misusing 340B Program at U.S. House Hearing

April 28, 2026 Shannon Young, Managing Editor 340B Report Views

Republican members of a key U.S. House panel on Tuesday criticized some 340B urban hospitals’ use of a rural designation—accusing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Hospital Group Again Asks HRSA to Address Drugmakers’ 340B In-House Pharmacy Claims Data Requirements

Federal Judge Strikes Down North Dakota’s 340B Contract Pharmacy Access Law